Baxter Holding B.V.

Φαρμακευτικά σκευάσματα

Η εταιρεία έχει λάβει από τις αρμόδιες αρχές άδεια κυκλοφορίας για τα παρακάτω φαρμακευτικά σκευάσματα:

Κωδικός	Όνομα	Κ	Ν.Τ.	Χ.Τ.	Λ.Τ.	Κάτοχος άδειας
22581.01.01	CAELYX PEGYLATED LIPOSOMAL C/S.SOL.IN 2MG/ML 1VIALX10ML		269,38	299,61	355,69	Baxter Holding B.V.
32290.01.01	DEXMEDETOMIDINE/BAXTER C/S.SOL.IN 100MCG/ML BT X 5 VIALS X 2ML		50,35	57,87	73,61	Baxter Holding B.V.
32368.01.01	LINEZOLID/BAXTER SOL.INF 2MG/ML BTx5 BAGS {PolyOlefin (PVC-free)} x 300ml		89,75	103,16	126,84	Baxter Holding B.V.
33312.01.01	PEMETREXED BAXTER PD.C.SO.IN 100MG/VIAL BT X 1 VIAL		86,00	98,85	125,74	Baxter Holding B.V.
33312.02.01	PEMETREXED BAXTER PD.C.SO.IN 500MG/VIAL BT X 1 VIAL		430,01	478,25	552,57	Baxter Holding B.V.
32414.01.06	PROPOFOL/BAXTER INJ.EM.IN 10MG/ML BTx1x100 ML (colourless glass vial-type II) (colourless glass vial-type II)		3,66	4,21	5,80	Baxter Holding B.V.
32414.01.04	PROPOFOL/BAXTER INJ.EM.IN 10MG/ML BTx1x50 ML (colourless glass vial-type II) (colourless glass vial-type II)		1,83	2,11	2,90	Baxter Holding B.V.
32414.01.02	PROPOFOL/BAXTER INJ.EM.IN 10MG/ML BTx5x20 ML (colourless glass vial-type II)		3,65	4,20	5,79	Baxter Holding B.V.
29149.01.06	SPIVA INJ.EM.IN 10MG/ML BTx1x100 ML (colourless glass vial-type II) (colourless glass vial-type II)		3,83	4,41	6,07	Baxter Holding B.V.
29149.01.04	SPIVA INJ.EM.IN 10MG/ML BTx1x50 ML (colourless glass vial-type II) (colourless glass vial-type II)		2,23	2,56	3,53	Baxter Holding B.V.
29149.01.02	SPIVA INJ.EM.IN 10MG/ML BTx5x20 ML (colourless glass vial-type II)		3,82	4,40	6,06	Baxter Holding B.V.
33052.01.01	SUGAMMADEX/BAXTER INJ.SOL 100MG/ML BT X 10 VIALS X 2ML		412,30	458,57	529,83	Baxter Holding B.V.
33052.01.02	SUGAMMADEX/BAXTER INJ.SOL 100MG/ML BT X 10 VIALS X 5ML		1.051,79	1.169,81	1.302,00	Baxter Holding B.V.